Sanofi provided insight into the logistics hurdles faced by vaccine makers in China after distribution and sales rule changes were made in response to illegal vaccine sales.
Michael Landberg, strategic global sourcing manager at Boston Scientific, describes how a major player in life-sciences approaches the critical issue of risk management.
Pfizer will build a biologics plant in China, where it will make biosimilars for the Chinese market but also for sale throughout the world. The New York drugmaker has turned to GE for construction of the facility, which has developed a modular construction process that will cut the cost and allow the plant to be operational in about 18 months, instead of three years.
Since opening last month, the new Stanford Children's Health Specialty Services - Sunnyvale clinic has received the best patient satisfaction survey results of any of Stanford Children's Health 60-some facilities. The health-care company attributes the high patient satisfaction levels, in large part, to a real-time location system that enables the staff to find patients, personnel and assets efficiently, says Lee Kwiatkowski, Stanford Children's Health's director of ambulatory transformation.